Effect of a Hop Extract Standardized in 8-Prenylnaringenin on Bone Health and Gut Microbiome in Postmenopausal Women with Osteopenia: A One-Year Randomized, Double-Blind, Placebo-Controlled Trial
Nutrients · 09.06.2023 · 15 (12) · 2688
DOI: 10.3390/nu15122688 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 09.06.2023. Verfasst von Manon Lecomte und 6 weiteren Autor:innen. Beteiligte Einrichtung: Givaudan France Naturals, 84911 Avignon, France. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Osteoporosis, Postmenopausal, Bone Diseases, Metabolic. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Givaudan France Naturals.
Abstract (Originalsprache)
Estrogen deficiency increases the risk of osteoporosis and fracture. The aim of this study was to investigate whether a hop extract standardized in 8-prenylnaringenin (8-PN), a potent phytoestrogen, could improve bone status of osteopenic women and to explore the gut microbiome roles in this effect. In this double-blind, placebo-controlled, randomized trial, 100 postmenopausal, osteopenic women were supplemented with calcium and vitamin D3 (CaD) tablets and either a hop extract (HE) standardized in 8-PN (n = 50) or a placebo (n = 50) for 48 weeks. Bone mineral density (BMD) and bone metabolism were assessed by DXA measurements and plasma bone biomarkers, respectively. Participant’s quality of life (SF-36), gut microbiome composition, and short-chain fatty acid (SCFA) levels were also investigated. In addition to the CaD supplements, 48 weeks of HE supplementation increased total body BMD (1.8 ± 0.4% vs. baseline, p < 0.0001; 1.0 ± 0.6% vs. placebo, p = 0.08), with a higher proportion of women experiencing an increase ≥1% compared to placebo (odds ratio: 2.41 ± 1.07, p < 0.05). An increase in the SF-36 physical functioning score was observed with HE versus placebo (p = 0.05). Gut microbiome α-diversity and SCFA levels did not differ between groups. However, a higher abundance of genera Turicibacter and Shigella was observed in the HE group; both genera have been previously identified as associated with total body BMD. These results suggest that an 8-PN standardized hop extract could beneficially impact bone health of postmenopausal women with osteopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Givaudan France Naturals, 84911 Avignon, France.
- Biofortis, 44800 Saint-Herblain, France.
- Service of Bone Disease, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.
- Rheumatology Department, Cork University Hospital, T12 DFK4 Cork, Ireland.
ORCID-Profile: Manon Lecomte, Diego Tomassi
Förderung
- Givaudan France Naturals
Zitieren
APA
Lecomte, M., Tomassi, D., Rizzoli, R., Tenon, M., Berton, T., Harney, S., & Fança-Berthon, P. (2023). Effect of a Hop Extract Standardized in 8-Prenylnaringenin on Bone Health and Gut Microbiome in Postmenopausal Women with Osteopenia: A One-Year Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 15(12), 2688. https://doi.org/10.3390/nu15122688
Vancouver
Lecomte M, Tomassi D, Rizzoli R, Tenon M, Berton T, Harney S, et al. Effect of a Hop Extract Standardized in 8-Prenylnaringenin on Bone Health and Gut Microbiome in Postmenopausal Women with Osteopenia: A One-Year Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2023;15(12):2688. doi:10.3390/nu15122688
BibTeX
@article{Lecomte2023,
author = {Lecomte, Manon and Tomassi, Diego and Rizzoli, René and Tenon, Mathieu and Berton, Thierry and Harney, Sinead and Fança-Berthon, Pascale},
title = {Effect of a Hop Extract Standardized in 8-Prenylnaringenin on Bone Health and Gut Microbiome in Postmenopausal Women with Osteopenia: A One-Year Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {12},
pages = {2688},
doi = {10.3390/nu15122688}
}
EUVIMED